11 December 2015 - Eli Lilly & Co. said Friday its new lung-cancer drug will cost about $11,430 a patient a month in the U. S.—well above what a group of doctors say is a fair price that reflects what they call the drug’s modest benefit.

For more details, go to: http://www.wsj.com/articles/lillys-lung-cancer-drug-portrazza-to-cost-11-430-a-month-1449867424